Summary
TEN years ago, Shire was a small, relatively unknown drugs company with a valuation of [pounds]100 million. Times have changed and it is now valued on the stock market at about [pounds]5 billion.
The company has transformed itself in recent years. Back in 2004, it was something of a one-trick pony, dominated by a single market, North America and a single drug, Adderall, for the treatment of attention deficit disorder.See the full content of this document
Extract
New Drugs Can Shine for Shire ; Midas
Today, it has a range of speciality drugs, designed primarily for niche markets.
The group has been ex...See the full content of this document
Sponsored links
